MetaADEDB 2.0 @ LMMD
Citalopram
(KTGRHKOEFSJQNS-BDQAORGHSA-N)
Structure
SMILES
OC(=O)C(=O)O.N#Cc1ccc2c(c1)CO[C@@]2(CCCN(C)C)c1ccc(cc1)F
Molecular Formula:
C22H23FN2O5
Molecular Weight:
414.427
Log P:
2.9686
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
110.86
CAS Number(s):
219861-08-2
Synonym(s)
1.
Citalopram
2.
Celexa
3.
Citalopram Hydrobromide
4.
Cytalopram
5.
Escitalopram
6.
Escitalopram Oxalate
7.
Lexapro
8.
Lu-10-171
9.
Seropram
10.
Lu10171
External Link(s)
MeSHD015283
PubChem Compound146571
BindingDB50323776
CHEMBLCHEMBL1200322
KEGGdr:D02567
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Completed SuicideFAERS: 171
Canada Vigilance: 6
Canada Vigilance
US FAERS
2AnxietyFAERS: 167
Canada Vigilance: 18
Canada Vigilance
US FAERS
3DizzinessFAERS: 150
Canada Vigilance: 26
Canada Vigilance
US FAERS
4NauseaFAERS: 147
Canada Vigilance: 31
Canada Vigilance
US FAERS
5Drug ineffectiveFAERS: 144
Canada Vigilance: 23
Canada Vigilance
US FAERS
6Feeling abnormalFAERS: 114
Canada Vigilance: 10
Canada Vigilance
US FAERS
7HeadacheFAERS: 96
Canada Vigilance: 19
Canada Vigilance
US FAERS
8FatigueFAERS: 87
Canada Vigilance: 7
Canada Vigilance
US FAERS
9TremorFAERS: 85
Canada Vigilance: 15
Canada Vigilance
US FAERS
10Product substitution issueFAERS: 76US FAERS
11AgitationFAERS: 73
Canada Vigilance: 12
Canada Vigilance
US FAERS
12Suicide attemptFAERS: 72
Canada Vigilance: 8
Canada Vigilance
US FAERS
13Drug exposure during pregnancyFAERS: 70US FAERS
14VomitingFAERS: 62
Canada Vigilance: 5
Canada Vigilance
US FAERS
15AmnesiaFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
16OverdoseFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Drug withdrawal syndromeFAERS: 49
Canada Vigilance: 3
Canada Vigilance
US FAERS
18MalaiseFAERS: 44
Canada Vigilance: 8
Canada Vigilance
US FAERS
19PregnancyFAERS: 43US FAERS
20SomnolenceFAERS: 43
Canada Vigilance: 8
Canada Vigilance
US FAERS
21AstheniaFAERS: 41
Canada Vigilance: 4
Canada Vigilance
US FAERS
22PalpitationsFAERS: 36
Canada Vigilance: 6
Canada Vigilance
US FAERS
23AngerFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
24TalipesFAERS: 34US FAERS
25PainFAERS: 32US FAERS
26Patent ductus arteriosusFAERS: 32US FAERS
27RestlessnessFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
28HypersensitivityFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
29Serotonin SyndromeFAERS: 31US FAERS
30Memory impairmentFAERS: 30US FAERS
31CryingFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
32TinnitusFAERS: 29
Canada Vigilance: 4
Canada Vigilance
US FAERS
33CraniosynostosisFAERS: 28US FAERS
34Depressed moodFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Weight decreasedFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Chest PainFAERS: 26US FAERS
37AlopeciaFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
38Impaired work abilityFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Intentional self-injuryFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
40NervousnessFAERS: 25
Canada Vigilance: 5
Canada Vigilance
US FAERS
41SyncopeFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
42Abdominal PainFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
43Sexual DysfunctionFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Drug dose omissionFAERS: 23US FAERS
45Emotional disorderFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
46nervous system disorderFAERS: 22US FAERS
47ParanoiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
48ArthralgiaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
49DystoniaFAERS: 19US FAERS
50Abdominal discomfortFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
51Erectile dysfunctionFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
52Hypoplastic Left Heart SyndromeFAERS: 18US FAERS
53Injury asphyxiationFAERS: 18US FAERS
54Mood swingsFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
55MyalgiaFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
56TachycardiaFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
57VertigoFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
58Medication ErrorFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
59PruritusFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
60Urinary RetentionFAERS: 17US FAERS
61Visual ImpairmentFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
62ChillsFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
63Drug exposure via breast milkFAERS: 16US FAERS
64Physical assaultFAERS: 16US FAERS
65AnorgasmiaFAERS: 15US FAERS
66Incorrect dose administeredFAERS: 15US FAERS
67LethargyFAERS: 15US FAERS
68Spina BifidaFAERS: 15US FAERS
69ThrombocytopeniaFAERS: 15US FAERS
70Unevaluable eventFAERS: 15US FAERS
71UrticariaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
72ApathyFAERS: 14US FAERS
73Disease recurrenceFAERS: 14US FAERS
74Impaired driving abilityFAERS: 14US FAERS
75Personality ChangeFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
76AsphyxiaFAERS: 13US FAERS
77DisorientationFAERS: 13US FAERS
78Activities of daily living impairedFAERS: 12US FAERS
79Burning sensationFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
80ConstipationFAERS: 12US FAERS
81DiscomfortFAERS: 12US FAERS
82DysgeusiaFAERS: 12US FAERS
83HostilityFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
84HypotensionFAERS: 12US FAERS
85Mental status changesFAERS: 12US FAERS
86PhotophobiaFAERS: 12US FAERS
87Product quality issueFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Restless Legs SyndromeFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
89TorticollisFAERS: 12US FAERS
90Blood cholesterol increasedFAERS: 11US FAERS
91Emotional distressFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
92HypersomniaFAERS: 11US FAERS
93Intentional product misuseFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Tardive DyskinesiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Atrial FibrillationFAERS: 10US FAERS
96Cardiac ArrestFAERS: 10US FAERS
97Cerebral disorderFAERS: 10US FAERS
98Cleft PalateFAERS: 10US FAERS
99MydriasisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
100Neck PainFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
101NephrolithiasisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
102SinusitisFAERS: 10US FAERS
103AkathisiaFAERS: 9US FAERS
104AnhedoniaFAERS: 9US FAERS
105Bipolar DisorderFAERS: 9US FAERS
106Blood sodium decreasedFAERS: 9US FAERS
107BradycardiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
108BruxismFAERS: 9US FAERS
109DiplopiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Drug dispensing errorFAERS: 9US FAERS
111Drug toxicityFAERS: 9US FAERS
112DysarthriaFAERS: 9US FAERS
113Euphoric moodFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
114FlushingFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
115Night sweatsFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Alanine Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Aspartate Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Bicuspid aortic valveFAERS: 8US FAERS
119Blood triglycerides increasedFAERS: 8US FAERS
120Drug DependenceFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
121DyspepsiaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
122Educational problemFAERS: 8US FAERS
123ErythemaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Feeling jitteryFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
125HydrocephalusFAERS: 8US FAERS
126Mental impairmentFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
127PetechiaeFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
128StressFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Visual disturbanceFAERS: 8US FAERS
130White blood cell count decreasedFAERS: 8US FAERS
131YawningFAERS: 8US FAERS
132treatment failureFAERS: 8US FAERS
133Angle Closure GlaucomaFAERS: 7US FAERS
134AnorexiaFAERS: 7US FAERS
135AphasiaFAERS: 7US FAERS
136Chest discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Congenital HydrocephalusFAERS: 7US FAERS
138DeafnessFAERS: 7US FAERS
139DissociationFAERS: 7US FAERS
140Economic problemFAERS: 7US FAERS
141FlatulenceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
142Inappropriate schedule of drug administrationFAERS: 7US FAERS
143Musculoskeletal stiffnessFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
144Myocardial InfarctionFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
145Neonatal disorderFAERS: 7US FAERS
146Obsessive-Compulsive DisorderFAERS: 7US FAERS
147PancreatitisFAERS: 7US FAERS
148Pharmaceutical product complaintFAERS: 7US FAERS
149PriapismFAERS: 7US FAERS
150Pulmonary Valve StenosisFAERS: 7US FAERS
151Pulmonary congestionFAERS: 7US FAERS
152ScreamingFAERS: 7US FAERS
153Wrong technique in product usage processFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
154Adverse eventFAERS: 6US FAERS
155ArteriosclerosisFAERS: 6US FAERS
156Back PainFAERS: 6US FAERS
157BlindnessFAERS: 6US FAERS
158Blood creatine phosphokinase increasedFAERS: 6US FAERS
159CardiomegalyFAERS: 6US FAERS
160Conversion disorderFAERS: 6US FAERS
161DeliriumFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Depressed Level of ConsciousnessFAERS: 6US FAERS
163Electrocardiogram abnormalFAERS: 6US FAERS
164EpistaxisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
165HomicideFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
166HyperventilationFAERS: 6US FAERS
167HypospadiasFAERS: 6US FAERS
168IncoherentFAERS: 6US FAERS
169LeukopeniaFAERS: 6US FAERS
170Muscle RigidityFAERS: 6US FAERS
171Nerve injuryFAERS: 6US FAERS
172Pulmonary HypertensionFAERS: 6US FAERS
173RetchingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Supraventricular tachycardiaFAERS: 6US FAERS
175TachyphreniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
176Atrioventricular Septal DefectFAERS: 5US FAERS
177Breast tendernessFAERS: 5US FAERS
178Cerebrovascular accidentFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
179CholelithiasisFAERS: 5US FAERS
180DehydrationFAERS: 5US FAERS
181Double Outlet Right VentricleFAERS: 5US FAERS
182Drug abuseFAERS: 5US FAERS
183Electroencephalogram abnormalFAERS: 5US FAERS
184ExcoriationFAERS: 5US FAERS
185Eye painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
186Feeling ColdFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Feelings of worthlessnessFAERS: 5US FAERS
188FormicationFAERS: 5US FAERS
189Hip DysplasiaFAERS: 5US FAERS
190HyperacusisFAERS: 5US FAERS
191InfectionFAERS: 5US FAERS
192InfluenzaFAERS: 5US FAERS
193MastitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
194Maternal exposure during pregnancyFAERS: 5US FAERS
195MegacolonFAERS: 5US FAERS
196MenorrhagiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
197MurderFAERS: 5US FAERS
198Muscle tightnessFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
199Musculoskeletal PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
200NeutropeniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Partner stressFAERS: 5US FAERS
202Respiratory distressFAERS: 5US FAERS
203Therapy cessationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
204ThrombosisFAERS: 5US FAERS
205Unresponsive to stimuliFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
206AbasiaFAERS: 4US FAERS
207Accidental overdoseFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
208Altered state of consciousnessFAERS: 4US FAERS
209Blood glucose decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
210Blood glucose increasedFAERS: 4US FAERS
211CataractFAERS: 4US FAERS
212Drug prescribing errorFAERS: 4US FAERS
213DysuriaFAERS: 4US FAERS
214Ear discomfortFAERS: 4US FAERS
215EpilepsyFAERS: 4US FAERS
216Feeding disorder neonatalFAERS: 4US FAERS
217Flat affectFAERS: 4US FAERS
218Food AllergyFAERS: 4US FAERS
219General physical health deteriorationFAERS: 4US FAERS
220Head discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
221HepatomegalyFAERS: 4US FAERS
222HerniaFAERS: 4US FAERS
223Hypertensive crisisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
224Intentional misuseFAERS: 4US FAERS
225Irritable Bowel SyndromeFAERS: 4US FAERS
226Joint swellingFAERS: 4US FAERS
227LacerationFAERS: 4US FAERS
228MetrorrhagiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
229MicrocephalyFAERS: 4US FAERS
230Obsessive thoughtsFAERS: 4US FAERS
231Optic NeuritisFAERS: 4US FAERS
232PallorFAERS: 4US FAERS
233PancytopeniaFAERS: 4US FAERS
234PresyncopeFAERS: 4US FAERS
235Pulmonary artery stenosisFAERS: 4US FAERS
236Rash erythematousFAERS: 4US FAERS
237Right Ventricular HypertrophyFAERS: 4US FAERS
238Sexual abuseFAERS: 4US FAERS
239Skin lacerationFAERS: 4US FAERS
240Wrong drug administeredFAERS: 4US FAERS
241Activation syndromeFAERS: 3US FAERS
242AgeusiaFAERS: 3US FAERS
243AngioedemaFAERS: 3US FAERS
244AsthmaFAERS: 3US FAERS
245AtaxiaFAERS: 3US FAERS
246Autoimmune thyroiditisFAERS: 3US FAERS
247Autonomic nervous system imbalanceFAERS: 3US FAERS
248Blood iron decreasedFAERS: 3US FAERS
249ChokingFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
250Cold sweatFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Complication of deliveryFAERS: 3US FAERS
252Complications of maternal exposure to therapeutic drugsFAERS: 3US FAERS
253Congenital pulmonary hypertensionFAERS: 3US FAERS
254Congenital torticollisFAERS: 3US FAERS
255Device malfunctionFAERS: 3US FAERS
256Dry gangreneFAERS: 3US FAERS
257EcchymosisFAERS: 3US FAERS
258EczemaFAERS: 3US FAERS
259Eye irritationFAERS: 3US FAERS
260Failure to ThriveFAERS: 3US FAERS
261Female Orgasmic DisorderFAERS: 3US FAERS
262Food cravingFAERS: 3US FAERS
263GlaucomaFAERS: 3US FAERS
264Guillain-Barre SyndromeFAERS: 3US FAERS
265Hallucinations, mixedFAERS: 3US FAERS
266HyperreflexiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
267HyperthyroidismFAERS: 3US FAERS
268HypokinesiaFAERS: 3US FAERS
269HypothyroidismFAERS: 3US FAERS
270IncontinenceFAERS: 3US FAERS
271InfarctionFAERS: 3US FAERS
272LymphadenopathyFAERS: 3US FAERS
273Male Orgasmic DisorderFAERS: 3US FAERS
274Multiple SclerosisFAERS: 3US FAERS
275Multiple drug overdoseFAERS: 3US FAERS
276NeuralgiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
277NystagmusFAERS: 3US FAERS
278OliguriaFAERS: 3US FAERS
279Oropharyngeal painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
280PneumoniaFAERS: 3US FAERS
281PolydipsiaFAERS: 3US FAERS
282Poor quality sleepFAERS: 3US FAERS
283Product formulation issueFAERS: 3US FAERS
284Product label issueFAERS: 3US FAERS
285Psychiatric symptomFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
286Pulmonary malformationFAERS: 3US FAERS
287Quality of life decreasedFAERS: 3US FAERS
288Respiratory DepressionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
289RhabdomyolysisFAERS: 3US FAERS
290Rheumatoid ArthritisFAERS: 3US FAERS
291ScotomaFAERS: 3US FAERS
292SepsisFAERS: 3US FAERS
293ShockFAERS: 3US FAERS
294Skin UlcerFAERS: 3US FAERS
295Skin lesionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
296Spina Bifida OccultaFAERS: 3US FAERS
297StaringFAERS: 3US FAERS
298StillbirthFAERS: 3US FAERS
299SubileusFAERS: 3US FAERS
300Sudden deathFAERS: 3US FAERS
301Therapeutic response unexpectedFAERS: 3US FAERS
302Throat irritationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Thyroid NeoplasmFAERS: 3US FAERS
304TrismusFAERS: 3US FAERS
305Urinary tract infectionFAERS: 3US FAERS
306Urine output increasedFAERS: 3US FAERS
307furuncleFAERS: 3US FAERS
308AcidosisFAERS: 2US FAERS
309Acute psychosisFAERS: 2US FAERS
310AgranulocytosisFAERS: 2US FAERS
311Alcohol abuseFAERS: 2US FAERS
312Alcohol interactionFAERS: 2US FAERS
313Alcohol poisoningFAERS: 2US FAERS
314AnosmiaFAERS: 2US FAERS
315Anoxic EncephalopathyFAERS: 2US FAERS
316Anticholinergic SyndromeFAERS: 2US FAERS
317AphagiaFAERS: 2US FAERS
318Apparent deathFAERS: 2US FAERS
319ArthropathyFAERS: 2US FAERS
320Back disorderFAERS: 2US FAERS
321Bipolar I disorderFAERS: 2US FAERS
322BlepharospasmFAERS: 2US FAERS
323Blood lactate dehydrogenase increasedFAERS: 2US FAERS
324Blood potassium decreasedFAERS: 2US FAERS
325Blood prolactin increasedFAERS: 2US FAERS
326Blood sodium increasedFAERS: 2US FAERS
327Blood testosterone decreasedFAERS: 2US FAERS
328BronchitisFAERS: 2US FAERS
329Butterfly rashFAERS: 2US FAERS
330CatatoniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
331Cerebral PalsyFAERS: 2US FAERS
332Cerebral ventricle dilatationFAERS: 2US FAERS
333ChoreaFAERS: 2US FAERS
334ClonusFAERS: 2US FAERS
335ClumsinessFAERS: 2US FAERS
336Cluster HeadacheFAERS: 2US FAERS
337Complex partial seizuresFAERS: 2US FAERS
338DementiaFAERS: 2US FAERS
339Dental cariesFAERS: 2US FAERS
340DextrocardiaFAERS: 2US FAERS
341Diabetes MellitusFAERS: 2US FAERS
342Diaphragmatic HerniaFAERS: 2US FAERS
343Disturbance in sexual arousalFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
344Drug effect incompleteFAERS: 2US FAERS
345Drug level increasedFAERS: 2US FAERS
346Drug screen false positiveFAERS: 2US FAERS
347Drug screen positiveFAERS: 2US FAERS
348Dry skinFAERS: 2US FAERS
349Ectopic kidneyFAERS: 2US FAERS
350EncephaloceleFAERS: 2US FAERS
351EncephalomalaciaFAERS: 2US FAERS
352EructationFAERS: 2US FAERS
353Facial ParesisFAERS: 2US FAERS
354Feeling of body temperature changeFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
355Foaming at mouthFAERS: 2US FAERS
356FractureFAERS: 2US FAERS
357FrustrationFAERS: 2US FAERS
358Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
359Gastric mucosal lesionFAERS: 2US FAERS
360GastroschisisFAERS: 2US FAERS
361Gestational DiabetesFAERS: 2US FAERS
362Head titubationFAERS: 2US FAERS
363HepatitisFAERS: 2US FAERS
364HepatotoxicityFAERS: 2US FAERS
365HydronephrosisFAERS: 2US FAERS
366HyperphagiaFAERS: 2US FAERS
367HypomaniaFAERS: 2US FAERS
368HypotrichosisFAERS: 2US FAERS
369ImmobileFAERS: 2US FAERS
370Impaired gastric emptyingFAERS: 2US FAERS
371Impaired self-careFAERS: 2US FAERS
372Inappropriate affectFAERS: 2US FAERS
373Increased tendency to bruiseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Intellectual DisabilityFAERS: 2US FAERS
375Intentional dose omissionFAERS: 2US FAERS
376Labile blood pressureFAERS: 2US FAERS
377LeukocytosisFAERS: 2US FAERS
378Libido disorderFAERS: 2US FAERS
379Lichen PlanusFAERS: 2US FAERS
380Limb discomfortFAERS: 2US FAERS
381Low density lipoprotein increasedFAERS: 2US FAERS
382Macular degenerationFAERS: 2US FAERS
383Male sexual dysfunctionFAERS: 2US FAERS
384Morbid thoughtsFAERS: 2US FAERS
385Motion SicknessFAERS: 2US FAERS
386Muscle SpasticityFAERS: 2US FAERS
387MyoclonusFAERS: 2US FAERS
388MyopiaFAERS: 2US FAERS
389NasopharyngitisFAERS: 2US FAERS
390Neonatal cardiac failureFAERS: 2US FAERS
391Neonatal respiratory depressionFAERS: 2US FAERS
392No adverse effectFAERS: 2US FAERS
393No adverse eventFAERS: 2US FAERS
394Oculogyric crisisFAERS: 2US FAERS
395OligohydramniosFAERS: 2US FAERS
396OsteopeniaFAERS: 2US FAERS
397OsteoporosisFAERS: 2US FAERS
398Pharyngolaryngeal PainFAERS: 2US FAERS
399PlagiocephalyFAERS: 2US FAERS
400PolyuriaFAERS: 2US FAERS
401Post procedural complicationFAERS: 2US FAERS
402Post-Traumatic Stress DisorderFAERS: 2US FAERS
403Premature EjaculationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
404Prescription drug used without a prescriptionFAERS: 2US FAERS
405Product dispensing errorFAERS: 2US FAERS
406Productive CoughFAERS: 2US FAERS
407Pulmonary EmbolismFAERS: 2US FAERS
408Pulmonary arterial hypertensionFAERS: 2US FAERS
409PurpuraFAERS: 2US FAERS
410PyelocaliectasisFAERS: 2US FAERS
411Pyloric StenosisFAERS: 2US FAERS
412Rebound effectFAERS: 2US FAERS
413Refusal of treatment by relativeFAERS: 2US FAERS
414Respiratory arrestFAERS: 2US FAERS
415Right atrial dilatationFAERS: 2US FAERS
416SarcoidosisFAERS: 2US FAERS
417SchizophreniaFAERS: 2US FAERS
418ShopliftingFAERS: 2US FAERS
419Skin irritationFAERS: 2US FAERS
420SluggishnessFAERS: 2US FAERS
421Subcutaneous AbscessFAERS: 2US FAERS
422SwellingFAERS: 2US FAERS
423SyndactylyFAERS: 2US FAERS
424TensionFAERS: 2US FAERS
425Tethered Cord SyndromeFAERS: 2US FAERS
426Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
427Therapy non-responderFAERS: 2US FAERS
428ThirstFAERS: 2US FAERS
429Toxicity to various agentsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
430Vaginal abscessFAERS: 2US FAERS
431Ventricular FibrillationFAERS: 2US FAERS
432Victim of sexual abuseFAERS: 2US FAERS
433Vitamin D DeficiencyFAERS: 2US FAERS
434Wheelchair userFAERS: 2US FAERS
435WheezingFAERS: 2US FAERS
436Wrong technique in drug usage processFAERS: 2US FAERS
437muscle injuryFAERS: 2US FAERS
438Abdominal tendernessFAERS: 1US FAERS
439Abnormal palmar/plantar creasesFAERS: 1US FAERS
440Abnormal weight gainFAERS: 1US FAERS
441AbscessFAERS: 1US FAERS
442Accidental drug intake by childFAERS: 1US FAERS
443AcneFAERS: 1US FAERS
444Acute myocardial infarctionFAERS: 1US FAERS
445Acute sinusitisFAERS: 1US FAERS
446AgoraphobiaFAERS: 1US FAERS
447Alopecia AreataFAERS: 1US FAERS
448Altered visual depth perceptionFAERS: 1US FAERS
449Ammonia increasedFAERS: 1US FAERS
450Amniotic cavity disorderFAERS: 1US FAERS
451Angina PectorisFAERS: 1US FAERS
452Animal scratchFAERS: 1US FAERS
453Antibody test positiveFAERS: 1US FAERS
454Antidepressant drug level increasedFAERS: 1US FAERS
455AnuriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Aortic AneurysmFAERS: 1US FAERS
457Aortic Valve ProlapseFAERS: 1US FAERS
458AphoniaFAERS: 1US FAERS
459Aqueductal StenosisFAERS: 1US FAERS
460AsthenopiaFAERS: 1US FAERS
461Autoimmune PancreatitisFAERS: 1US FAERS
462Autoimmune hepatitisFAERS: 1US FAERS
463BedriddenFAERS: 1US FAERS
464Benign Prostatic HyperplasiaFAERS: 1US FAERS
465Bilirubin conjugated increasedFAERS: 1US FAERS
466Bipolar II disorderFAERS: 1US FAERS
467Bladder painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
468Blood alcohol increasedFAERS: 1US FAERS
469Blood alkaline phosphatase increasedFAERS: 1US FAERS
470Blood amylase increasedFAERS: 1US FAERS
471Blood citric acid increasedFAERS: 1US FAERS
472Blood creatine increasedFAERS: 1US FAERS
473Blood creatine phosphokinase MB abnormalFAERS: 1US FAERS
474Blood creatinine increasedFAERS: 1US FAERS
475Blood fibrinogen decreasedFAERS: 1US FAERS
476Blood follicle stimulating hormone increasedFAERS: 1US FAERS
477Blood glucose fluctuationFAERS: 1US FAERS
478Blood magnesium decreasedFAERS: 1US FAERS
479Blood pH decreasedFAERS: 1US FAERS
480Blood phosphorus abnormalFAERS: 1US FAERS
481Blood potassium abnormalFAERS: 1US FAERS
482Blood urea increasedFAERS: 1US FAERS
483Blood urine presentFAERS: 1US FAERS
484Body temperature fluctuationFAERS: 1US FAERS
485Brain natriuretic peptide increasedFAERS: 1US FAERS
486Breath HoldingFAERS: 1US FAERS
487Bronchoscopy abnormalFAERS: 1US FAERS
488BronchospasmFAERS: 1US FAERS
489Bulimia NervosaFAERS: 1US FAERS
490Burning Mouth SyndromeFAERS: 1US FAERS
491CachexiaFAERS: 1US FAERS
492CalcinosisFAERS: 1US FAERS
493CandidiasisFAERS: 1US FAERS
494Carbon dioxide increasedFAERS: 1US FAERS
495Carcinoembryonic antigen increasedFAERS: 1US FAERS
496Cardiac FlutterFAERS: 1US FAERS
497Cardiac infectionFAERS: 1US FAERS
498Cerebral InfarctionFAERS: 1US FAERS
499Cerebral ThrombosisFAERS: 1US FAERS
500Cerebral atrophyFAERS: 1US FAERS
501Cerebral cystFAERS: 1US FAERS
502Cerebral dysgenesisFAERS: 1US FAERS
503Cervicobrachial syndromeFAERS: 1US FAERS
504CheilitisFAERS: 1US FAERS
505CholestasisFAERS: 1US FAERS
506ChoreoathetosisFAERS: 1US FAERS
507ColitisFAERS: 1US FAERS
508Compulsive shoppingFAERS: 1US FAERS
509Congenital cystic kidney diseaseFAERS: 1US FAERS
510Congenital diaphragmatic herniaFAERS: 1US FAERS
511Congenital heart valve disorderFAERS: 1US FAERS
512Congenital hydronephrosisFAERS: 1US FAERS
513Congenital renal disorderFAERS: 1US FAERS
514Consciousness fluctuatingFAERS: 1US FAERS
515Conus Medullaris SyndromeFAERS: 1US FAERS
516Coronary Artery DiseaseFAERS: 1US FAERS
517Culture urine positiveFAERS: 1US FAERS
518CyanosisFAERS: 1US FAERS
519Cyclic neutropeniaFAERS: 1US FAERS
520Cyclothymic DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
521Cytolytic hepatitisFAERS: 1US FAERS
522Death of relativeFAERS: 1US FAERS
523Deep Vein ThrombosisFAERS: 1US FAERS
524Delusional disorder, persecutory typeFAERS: 1US FAERS
525Delusional disorder, unspecified typeFAERS: 1US FAERS
526Dissociative Identity DisorderFAERS: 1US FAERS
527Dissociative disorderFAERS: 1US FAERS
528DrowningFAERS: 1US FAERS
529Drug administered to patient of inappropriate ageFAERS: 1US FAERS
530Drug dose titration not performedFAERS: 1US FAERS
531Drug exposure before pregnancyFAERS: 1US FAERS
532Drug ineffective for unapproved indicationFAERS: 1US FAERS
533Drug titration errorFAERS: 1US FAERS
534Drug withdrawal convulsionsFAERS: 1US FAERS
535Drug-disease interactionFAERS: 1US FAERS
536Duodenal atresiaFAERS: 1US FAERS
537DysgraphiaFAERS: 1US FAERS
538DysmorphismFAERS: 1US FAERS
539DysphemiaFAERS: 1US FAERS
540DysphoniaFAERS: 1US FAERS
541EclampsiaFAERS: 1US FAERS
542Electrocardiogram changeFAERS: 1US FAERS
543Electrocardiogram delta waves abnormalFAERS: 1US FAERS
544Electrolyte imbalanceFAERS: 1US FAERS
545Elevated moodFAERS: 1US FAERS
546EncephalitisFAERS: 1US FAERS
547EndometriosisFAERS: 1US FAERS
548Epigastric discomfortFAERS: 1US FAERS
549EpispadiasFAERS: 1US FAERS
550ErythropeniaFAERS: 1US FAERS
551Escherichia infectionFAERS: 1US FAERS
552Excessive eye blinkingFAERS: 1US FAERS
553Exposure via fatherFAERS: 1US FAERS
554Eye BurnsFAERS: 1US FAERS
555Facial paralysisFAERS: 1US FAERS
556FibromyalgiaFAERS: 1US FAERS
557Flight of ideasFAERS: 1US FAERS
558Food PoisoningFAERS: 1US FAERS
559Frustration tolerance decreasedFAERS: 1US FAERS
560GamblingFAERS: 1US FAERS
561Gastric DilatationFAERS: 1US FAERS
562Gastric ulcerFAERS: 1US FAERS
563GastritisFAERS: 1US FAERS
564Gastrointestinal PainFAERS: 1US FAERS
565Gastrointestinal inflammationFAERS: 1US FAERS
566Gastrointestinal sounds abnormalFAERS: 1US FAERS
567Gaze palsyFAERS: 1US FAERS
568Global AmnesiaFAERS: 1US FAERS
569GoutFAERS: 1US FAERS
570Granulocyte count decreasedFAERS: 1US FAERS
571Granulomatous liver diseaseFAERS: 1US FAERS
572Head BangingFAERS: 1US FAERS
573Heat ExhaustionFAERS: 1US FAERS
574Heat StrokeFAERS: 1US FAERS
575HemiplegiaFAERS: 1US FAERS
576HungerFAERS: 1US FAERS
577HypercalciuriaFAERS: 1US FAERS
578Hyperemesis GravidarumFAERS: 1US FAERS
579HyperoxaluriaFAERS: 1US FAERS
580Hypertrophic CardiomyopathyFAERS: 1US FAERS
581Hypoaesthesia facialFAERS: 1US FAERS
582HypometabolismFAERS: 1US FAERS
583HypophagiaFAERS: 1US FAERS
584HyporeflexiaFAERS: 1US FAERS
585HypoxiaFAERS: 1US FAERS
586ImmunosuppressionFAERS: 1US FAERS
587Impaired quality of lifeFAERS: 1US FAERS
588ImpatienceFAERS: 1US FAERS
589Inability to afford medicationFAERS: 1US FAERS
590Incisional herniaFAERS: 1US FAERS
591Incorrect drug administration durationFAERS: 1US FAERS
592Incorrect drug dosage form administeredFAERS: 1US FAERS
593Increased bronchial secretionFAERS: 1US FAERS
594Increased insulin requirementFAERS: 1US FAERS
595Infantile apnoeic attackFAERS: 1US FAERS
596Infectious MononucleosisFAERS: 1US FAERS
597InfertilityFAERS: 1US FAERS
598InflammationFAERS: 1US FAERS
599Insulin ResistanceFAERS: 1US FAERS
600Intentional product use issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
601Intercepted drug administration errorFAERS: 1US FAERS
602Intestinal infarctionFAERS: 1US FAERS
603Joint sprainFAERS: 1US FAERS
604Joint stiffnessFAERS: 1US FAERS
605Klippel-Feil SyndromeFAERS: 1US FAERS
606LaryngospasmFAERS: 1US FAERS
607Left Ventricular HypertrophyFAERS: 1US FAERS
608Left ventricle outflow tract obstructionFAERS: 1US FAERS
609Limb asymmetryFAERS: 1US FAERS
610Limb injuryFAERS: 1US FAERS
611Limb operationFAERS: 1US FAERS
612LipomaFAERS: 1US FAERS
613Low birth weight babyFAERS: 1US FAERS
614Low set earsFAERS: 1US FAERS
615Lupus-like syndromeFAERS: 1US FAERS
616Lymphocytic infiltrationFAERS: 1US FAERS
617MacrocephalyFAERS: 1US FAERS
618Macular fibrosisFAERS: 1US FAERS
619Malignant HypertensionFAERS: 1US FAERS
620MalnutritionFAERS: 1US FAERS
621Markedly reduced dietary intakeFAERS: 1US FAERS
622Mastication disorderFAERS: 1US FAERS
623Maternal exposure before pregnancyFAERS: 1US FAERS
624Maternal exposure during deliveryFAERS: 1US FAERS
625Medication overuse headacheFAERS: 1US FAERS
626MeningiomaFAERS: 1US FAERS
627Mental RetardationFAERS: 1US FAERS
628Metabolic acidosisFAERS: 1US FAERS
629MetamorphopsiaFAERS: 1US FAERS
630Metastases to stomachFAERS: 1US FAERS
631MetastasisFAERS: 1US FAERS
632Metastatic NeoplasmFAERS: 1US FAERS
633Middle insomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
634MonoplegiaFAERS: 1US FAERS
635Multiple drug overdose intentionalFAERS: 1US FAERS
636Muscle strainFAERS: 1US FAERS
637Musculoskeletal chest painFAERS: 1US FAERS
638MyopathyFAERS: 1US FAERS
639Nasal discomfortFAERS: 1US FAERS
640Nasal inflammationFAERS: 1US FAERS
641Negative thoughtsFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
642Neonatal multi-organ failureFAERS: 1US FAERS
643Neonatal respiratory arrestFAERS: 1US FAERS
644Nonspecific reactionFAERS: 1US FAERS
645Ocular icterusFAERS: 1US FAERS
646Ocular vascular disorderFAERS: 1US FAERS
647Optic AtrophyFAERS: 1US FAERS
648Orgasmic sensation decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
649Orthostatic hypertensionFAERS: 1US FAERS
650Orthostatic intoleranceFAERS: 1US FAERS
651PO2 decreasedFAERS: 1US FAERS
652Panic DisorderFAERS: 1US FAERS
653ParaplegiaFAERS: 1US FAERS
654Peptic UlcerFAERS: 1US FAERS
655PericarditisFAERS: 1US FAERS
656Perineal fistulaFAERS: 1US FAERS
657Pharmaceutical product counterfeitFAERS: 1US FAERS
658Pharyngeal swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
659Physical disabilityFAERS: 1US FAERS
660Platelet adhesiveness increasedFAERS: 1US FAERS
661Pleuritic painFAERS: 1US FAERS
662PneumonitisFAERS: 1US FAERS
663PneumothoraxFAERS: 1US FAERS
664PoisoningFAERS: 1US FAERS
665Polysubstance abuseFAERS: 1US FAERS
666Poor weight gain neonatalFAERS: 1US FAERS
667Postictal headacheFAERS: 1US FAERS
668Postoperative wound complicationFAERS: 1US FAERS
669Pre-EclampsiaFAERS: 1US FAERS
670Pregnancy of partnerFAERS: 1US FAERS
671Premature MenopauseFAERS: 1US FAERS
672Premenstrual syndromeFAERS: 1US FAERS
673Prescribed overdoseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
674Product contaminationFAERS: 1US FAERS
675Product counterfeitFAERS: 1US FAERS
676Product dose omissionFAERS: 1US FAERS
677Product expiration date issueFAERS: 1US FAERS
678Product lot number issueFAERS: 1US FAERS
679Product physical issueFAERS: 1US FAERS
680Product prescribing issueFAERS: 1US FAERS
681Product solubility abnormalFAERS: 1US FAERS
682Product use issueFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
683ProstatectomyFAERS: 1US FAERS
684PseudocystFAERS: 1US FAERS
685PsoriasisFAERS: 1US FAERS
686Psychiatric decompensationFAERS: 1US FAERS
687Psychiatric evaluationFAERS: 1US FAERS
688Pulmonary FibrosisFAERS: 1US FAERS
689Pulmonary vascular disorderFAERS: 1US FAERS
690PurulenceFAERS: 1US FAERS
691Purulent dischargeFAERS: 1US FAERS
692Radicular painFAERS: 1US FAERS
693Reaction to drug excipientsFAERS: 1US FAERS
694Rectal dischargeFAERS: 1US FAERS
695Renal painFAERS: 1US FAERS
696Respiratory FailureFAERS: 1US FAERS
697Respiratory tract infection fungalFAERS: 1US FAERS
698Retinal DetachmentFAERS: 1US FAERS
699RhinitisFAERS: 1US FAERS
700Right ventricle outflow tract obstructionFAERS: 1US FAERS
701School refusalFAERS: 1US FAERS
702SclerodermaFAERS: 1US FAERS
703Self MutilationFAERS: 1US FAERS
704Semen analysis abnormalFAERS: 1US FAERS
705Senile dementiaFAERS: 1US FAERS
706Shoulder PainFAERS: 1US FAERS
707Sickle Cell TraitFAERS: 1US FAERS
708Single functional kidneyFAERS: 1US FAERS
709Sinus TachycardiaFAERS: 1US FAERS
710Skeleton dysplasiaFAERS: 1US FAERS
711Skin tightnessFAERS: 1US FAERS
712Sleep TalkingFAERS: 1US FAERS
713Sleep sexFAERS: 1US FAERS
714SneezingFAERS: 1US FAERS
715SoporFAERS: 1US FAERS
716Sperm count decreasedFAERS: 1US FAERS
717SpermatoceleFAERS: 1US FAERS
718Spermatozoa progressive motility decreasedFAERS: 1US FAERS
719Stevens-Johnson SyndromeFAERS: 1US FAERS
720Stress at workFAERS: 1US FAERS
721Sudden onset of sleepFAERS: 1US FAERS
722Suppressed lactationFAERS: 1US FAERS
723Suspected counterfeit productFAERS: 1US FAERS
724SynostosisFAERS: 1US FAERS
725SyringomyeliaFAERS: 1US FAERS
726Temperature intoleranceFAERS: 1US FAERS
727Tension HeadacheFAERS: 1US FAERS
728TetanyFAERS: 1US FAERS
729TheftFAERS: 1US FAERS
730Therapeutic response changedFAERS: 1US FAERS
731Therapy changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
732Thermal burnFAERS: 1US FAERS
733Thoracic vertebral fractureFAERS: 1US FAERS
734ThyroiditisFAERS: 1US FAERS
735Tobacco userFAERS: 1US FAERS
736Tongue bitingFAERS: 1US FAERS
737Tongue spasmFAERS: 1US FAERS
738Tonic clonic movementsFAERS: 1US FAERS
739Tooth ErosionFAERS: 1US FAERS
740Tooth ExtractionFAERS: 1US FAERS
741Toxicologic test abnormalFAERS: 1US FAERS
742ToxoplasmosisFAERS: 1US FAERS
743Transaminases increasedFAERS: 1US FAERS
744Traumatic Brain InjuryFAERS: 1US FAERS
745TrichotillomaniaFAERS: 1US FAERS
746Trisomy 21FAERS: 1US FAERS
747UlcerFAERS: 1US FAERS
748UnderweightFAERS: 1US FAERS
749UnemploymentFAERS: 1US FAERS
750Urinary IncontinenceFAERS: 1US FAERS
751Urine osmolarity decreasedFAERS: 1US FAERS
752Uterine CancerFAERS: 1US FAERS
753UveitisFAERS: 1US FAERS
754Vaginal FistulaFAERS: 1US FAERS
755Vascular anomalyFAERS: 1US FAERS
756VasculitisFAERS: 1US FAERS
757Ventricular arrhythmiaFAERS: 1US FAERS
758Ventricular hypoplasiaFAERS: 1US FAERS
759Violence-related symptomFAERS: 1US FAERS
760Visual brightnessFAERS: 1US FAERS
761Vitamin AFAERS: 1US FAERS
762Vitamin DFAERS: 1US FAERS
763Vitreous floatersFAERS: 1US FAERS
764Vitreous opacitiesFAERS: 1US FAERS
765Vulvovaginal drynessFAERS: 1US FAERS
766Vulvovaginal rashFAERS: 1US FAERS
767Walking aid userFAERS: 1US FAERS
768Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
769ovarian neoplasmFAERS: 1US FAERS
770Acute kidney injuryCanada Vigilance: 1Canada Vigilance
771Alopecia totalisCanada Vigilance: 1Canada Vigilance
772Ankle FractureCanada Vigilance: 1Canada Vigilance
773Binge DrinkingCanada Vigilance: 1Canada Vigilance
774Breast engorgementCanada Vigilance: 1Canada Vigilance
775ChromaturiaCanada Vigilance: 1Canada Vigilance
776Enzyme abnormalityCanada Vigilance: 1Canada Vigilance
777Exposure via breast milkCanada Vigilance: 1Canada Vigilance
778HypohidrosisCanada Vigilance: 1Canada Vigilance
779Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
780Initial insomniaCanada Vigilance: 1Canada Vigilance
781Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
782OpisthotonusCanada Vigilance: 1Canada Vigilance
783Pain of skinCanada Vigilance: 1Canada Vigilance
784Peripheral swellingCanada Vigilance: 1Canada Vigilance
785Shock symptomCanada Vigilance: 1Canada Vigilance
786Somatic symptom disorderCanada Vigilance: 1Canada Vigilance
787SomnambulismCanada Vigilance: 1Canada Vigilance
788StuporCanada Vigilance: 1Canada Vigilance
789Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
790Therapeutic product effect incompleteCanada Vigilance: 1Canada Vigilance
791Therapeutic product ineffectiveCanada Vigilance: 2Canada Vigilance
792Tongue movement disturbanceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.